* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 5800 | PTPRO | C0017668 | Focal glomerulosclerosis | 0.200549453568426 | BEFREE;HPO |
| 5800 | PTPRO | C0027726 | Nephrotic Syndrome | 0.200549453568426 | BEFREE;HPO |
| 5800 | PTPRO | C0013604 | Edema | 0.2 | HPO |
| 5800 | PTPRO | C0023893 | Liver Cirrhosis, Experimental | 0.2 | CTD_human |
| 5800 | PTPRO | C0023903 | Liver neoplasms | 0.2 | CTD_human |
| 5800 | PTPRO | C0025202 | melanoma | 0.2 | CTD_human |
| 5800 | PTPRO | C0033687 | Proteinuria | 0.2 | HPO |
| 5800 | PTPRO | C0239981 | Hypoalbuminemia | 0.2 | HPO |
| 5800 | PTPRO | C1861403 | Variable expressivity | 0.2 | HPO |
| 5800 | PTPRO | C1866862 | Highly variable severity | 0.2 | HPO |
| 5800 | PTPRO | C1969372 | Tubulointerstitial fibrosis | 0.2 | HPO |
| 5800 | PTPRO | C4020899 | Autosomal recessive predisposition | 0.2 | HPO |
| 5800 | PTPRO | C0023434 | Chronic Lymphocytic Leukemia | 0.00355709281745305 | BEFREE;LHGDN |
| 5800 | PTPRO | C0023418 | leukemia | 0.00328236603323995 | BEFREE;LHGDN |
| 5800 | PTPRO | C0024121 | Lung Neoplasms | 0.00300763924902685 | BEFREE;LHGDN |
| 5800 | PTPRO | C0024299 | Lymphoma | 0.00273291246481375 | LHGDN |
| 5800 | PTPRO | C1458155 | Mammary Neoplasms | 0.00273291246481375 | LHGDN |
| 5800 | PTPRO | C0040336 | Tobacco Use Disorder | 0.002407028523288 | GAD |
| 5800 | PTPRO | C0006142 | Malignant neoplasm of breast | 0.0008241803526393 | BEFREE |
| 5800 | PTPRO | C0678222 | Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 5800 | PTPRO | C0268731 | Renal glomerular disease | 0.0005494535684262 | BEFREE |
| 5800 | PTPRO | C0596263 | Carcinogenesis | 0.0005494535684262 | BEFREE |
| 5800 | PTPRO | C0019158 | Hepatitis | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0020538 | Hypertensive disease | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0023449 | Acute lymphocytic leukemia | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0023473 | Myeloid Leukemia, Chronic | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0023895 | Liver diseases | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0027697 | Nephritis | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0079731 | B-Cell Lymphomas | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0279626 | Squamous cell carcinoma of esophagus | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0302809 | Fulminant hepatitis | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0345904 | Malignant neoplasm of liver | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C0598766 | Leukemogenesis | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C1512409 | Hepatocarcinogenesis | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C1709661 | Primary Focal Segmental Glomerulosclerosis | 0.0002747267842131 | BEFREE |
| 5800 | PTPRO | C2239176 | Liver carcinoma | 0.0002747267842131 | BEFREE |